Janux Therapeutics’ shares closed up 14% at $15.14, after it announced a collaboration and exclusive worldwide license ...
UK pharma major GSK’s Nucala (mepolizumab) has recently received approval in China as add-on maintenance treatment for adults ...
The Gates Foundation, Novo Nordisk Foundation, and Wellcome have said they will award $60 million in new grant funding over ...
US clinical-stage biotech Corxel Pharmaceuticals, dedicated to developing innovative therapies for patients with ...
San Francisco-based Mendra, a biopharma aiming to advance promising therapies for rare disease medicines, has announced its ...
DelveInsight says the cystinosis treatment market across the USA, EU4, UK and Japan totaled about $250 million in 2024, with ...
US pharma major Gilead Sciences (Nasdaq: GILD) says The New England Journal of Medicine has published full Phase III data for ...
US healthcare company Sagebrush Health Services, a non-profit organization serving more than 10,000 Nevada patients, has ...
India’s Zydus Lifesciences, an innovation-led life-sciences company with an international presence, has launched the world’s first biosimilar of nivolumab in India under the brand name Tishtha, ...
Texas, USA-based IntraBio revealed that the European Commission granted marketing authorization to Aqneursa (levacetylleucine ...
A U.S.-based clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The company conducts ...
The 44th Annual JP Morgan Healthcare Conference saw a focus on internal pipeline prioritization and bolt-on licensing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback